ImportRefusal LogoImportRefusal

PREMIUMA TU SALUD

⚠️ Moderate Risk

FEI: 3015161698 • Monterrey, Nuevo Leon • MEXICO

FEI

FEI Number

3015161698

📍

Location

Monterrey, Nuevo Leon

🇲🇽

Country

MEXICO
🏢

Address

Cipres 150 Fracc Cumbre, , Monterrey, Nuevo Leon, Mexico

Moderate Risk

FDA Import Risk Assessment

37.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
4
Unique Violations
7/1/2025
Latest Refusal
7/1/2025
Earliest Refusal

Score Breakdown

Violation Severity
37.5×40%
Refusal Volume
11.2×30%
Recency
89.2×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

Refusal History

DateProductViolationsDivision
7/1/2025
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
324NO ENGLISH
473LABELING
482NUTRIT LBL
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is PREMIUMA TU SALUD's FDA import refusal history?

PREMIUMA TU SALUD (FEI: 3015161698) has 1 FDA import refusal record(s) in our database, spanning from 7/1/2025 to 7/1/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. PREMIUMA TU SALUD's FEI number is 3015161698.

What types of violations has PREMIUMA TU SALUD received?

PREMIUMA TU SALUD has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about PREMIUMA TU SALUD come from?

All FDA import refusal data for PREMIUMA TU SALUD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.